Vilin Bio Med Limited IPO

Apply 0
Avoid 0

i. Vilin BIO Med Limited is a company that manufactures pharmaceutical formulations, such as oral liquids, dry syrups, sachets, external preparations, tablets, capsules, and nutritional food supplements.

ii. It also provides technology-based products and pre-formulation intermediates2, such as oral thin films for pharmaceutical and nutraceutical products.

iii. It partners with pharma and food supplement marketing companies, who seek solutions for the development and sourcing of their products for marketing.

iv. It was incorporated on 29 June 2005 and is based in Secunderabad, Telangana, India3. Its managing director is Viswa Prasad Sadhanala.

v. Some of the products manufactured by Vilin BIO Med Limited are:

a. Balatam 500mg Tablet: An antibiotic used to treat bacterial infections such as bronchitis, pneumonia, sinusitis, and skin infections.

b. Kepdox CV 200mg/125mg Tablet: A combination of cefpodoxime and clavulanic acid used to treat bacterial infections such as urinary tract infections, ear infections, throat infections, and lung infections.

c. Livoq 750mg Tablet: A fluoroquinolone antibiotic used to treat bacterial infections such as urinary tract infections, respiratory tract infections, skin infections, and bone and joint infections.

d. Rabistal 20mg Tablet: A proton pump inhibitor used to treat acid-related disorders such as gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome.

e. Rabistal D 30mg/40mg Capsule SR: A combination of domperidone and rabeprazole used to treat nausea, vomiting, and acid-related disorders such as gastroesophageal reflux disease and peptic ulcer disease.

Objects of the Vilin Bio Med Limited IPO:

The Company proposes to utilize the following objects:

1. Augmenting additional working capital requirements 2. General corporate purposes 3. Issue related expenses

DRHP of Vilin Bio Med Limited IPO
RHP of Vilin Bio Med Limited IPO

Vilin Bio Med Limited IPO Details:

Open Date: Jun 16 2023
Close Date: Jun 21 2023
Total Shares: 40,00,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Issue
Issue Size: 12 Cr.
Lot Size: 4000 Shares
Issue Price: ₹ 30 Per Equity Share
Listing At: NSE Emerge
Listing Date: Jun 30 2023

Financials of Vilin Bio Med Limited IPO:

A. Balance Sheet
Particular (In Lakhs) Mar-20 Mar-21 Mar-22 9MFY23
Equity Share Capital 330.00 330.00 330.00 330.00
Reserves 394 406 410 538
Borrowings 453 552 530 618
Trade Payables 186 82 64 118
Other Liabilities 37 20 22 83
Total Liabilities 676 653 616 819
Net Block 213 187 165 152
Other Assets 5 5 5 742
Total NC Assets 217 192 170 893
Receivables 727 765 779 541
Inventory 211 206 228 52
Cash & Bank 7 5 4 4
Other Assets 239 222 175 197
B. Profit & Loss Statement
Particular (In Lakhs) Mar-20 Mar-21 Mar-22 Mar-23
Sales 1,681 1,172 1,121 1,202
Raw Material Cost 1,392 906 888 744
Change in Inventory -20 -2 -1 12
Employee Cost 135 106 100 82
Other Expenses 84 76 58 52
Other Income 1 0.36 0.42 3
EBITDA 91 86 77 314
Depreciation 31 26 22 21
Interest 41 44 51 60
Profit before tax 19 16 4 233
Tax 3 4 1 62
Net profit 16 12 3 171
C. Cash Flow Statement
Particular (In Lakhs) Mar-20 Mar-21 Mar-22 9MFY23
Cash From Operating Activity
Profit From Operation 51 42 26 190
Receivable -115 -38 -14 237
Inventory -11 5 -22 177
Payable 84 -104 -18 54
Loans And Advances -120 17 44 -12
Other WC Items -31 -17 6 50
Working Capital Changes -193 -138 -5 506
Direct Taxes 4 4 1 45
Net Cash Inflow from Operating Activity -146 -100 21 651
Cash from Investing Activity
Fixed assets purchased -2 0 0 -3
Net cash inflow from investing activities -2 0 0 -3
Cash from Financing Activity
Proceeds from borrowings 151 102 7 110
Repayment of borrowings 0 3 28 759
Net Cash Flow 3 -2 -1 0.35
 

Comparison With Peers:

Name of the Company Revenue (In Crore) PAT (In Crore) EPS ( in Rs) P/E CMP Mcap (In Crore)
Vilin Bio Med Limited 12 1.7 1.22 24.5 30 41.8
JFL Life Sciences Limited 42.8 2.8 2.55 16 41 45
Vaishali Pharma Limited 69.7 6.6 6.26 20.7 129 136
Anuh Pharma Limited 527 36 7.22 13.6 98.2 492
* All the data is as per FY23.

Recommendation on Vilin Bio Med Limited IPO:

Review and Recommendation of Vilin Bio Med Limited by IZ team is  4/10 1. Vilin Bio Med Limited is a pharmaceutical manufacturing company based in Roorkee, Uttarakhand, India. They specialise in the domestic business of manufacturing pharmaceutical products. 2. Product Portfolio: The company manufactures oral liquids (syrups, suspensions, dry powders), tablets, capsules, and external preparations. 3.Operational Efficiency: Vilin Bio Med Limited focuses on achieving operational efficiency in terms of cost and production by implementing manufacturing standards and emphasising quality control and assurance. 4. Customer Base Enhancement: Vilin Bio Med Limited aims to expand its customer base by enhancing its geographical presence and distribution network while maintaining strong relationships with existing customers. 5. Logistics: The company relies on third-party transportation providers for the delivery of raw materials and finished products. They have a dedicated supply chain management team to oversee these operations. 6. Competition: Vilin Bio Med Limited faces competition from both domestic and global markets, and they acknowledge the importance of price in customers' decision-making process. 7. Overall, Vilin Bio Med Limited emphasises quality, operational efficiency, customer satisfaction, and regulatory compliance in its business model to remain competitive in the pharmaceutical industry. 8. The Revenue has Increased from Rs.16.8 Crore in FY20 to Rs.12 Crore in FY23. 9. The EBITDA has Increased from 91 Lakhs in FY20 to 3 Crore in FY23. 10. The PAT has Increased from 16 Lakhs in FY20 to 1.7 Crore in FY23. 11.As per FY23, CFO/EBITDA is 0.97, As per FY23, EPS is 1.22, 12. Market Capitalization is 41.8 Crore & P/E is 24.5x.

Lead Manager of Vilin Bio Med Limited IPO:

  1. Inventure Merchant Banker Services Private Limited

Registrar of Vilin Bio Med Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

Sy no 115, Hanumanji Colony Opp Sub Register Office, Old Bowenpally, Secunderabad - 500009, Hyderabad, Telangana - India

Discussion on Vilin Bio Med Limited IPO:

Leave a Reply